Suresh Ramalingam’s work and Conquer Cancer’s role in advancing cancer research
Conquer Cancer, the ASCO Foundation shared a post on LinkedIn:
“Conquer Cancer’s commitment to funding innovative research is exemplified by the work of Dr. Suresh Ramalingam, a 2006 Conquer Cancer grant recipient.
Dr. Ramalingam’s dedication to lung cancer research reached a significant milestone at the 2024 ASCO Annual Meeting, where he presented practice-changing results from the LAURA clinical trial.
Investing in early-career researchers through Conquer Cancer grants is essential to drive advancements in oncology. Learn more about the impact of our funding and other success stories in our 2024 impact report.
Learn more about Dr. Ramalingam’s work and Conquer Cancer’s role in advancing cancer research.”
More posts featuring Conquer Cancer, the ASCO Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023